High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/533358DF.svg?ark=w1%2F20260515%2F533358DF)](https://nobleid.org/work/w1/20260515/533358DF)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors